# Nuclide record novartis (company). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/companies/novartis/>
  a schema:Organization ;
  nuclide:kind "company" ;
  schema:identifier "novartis" ;
  schema:name "Novartis"@en ;
  schema:alternateName "Endocyte"@en ;
  schema:description "The company that made radioligand therapy a business, with Pluvicto and Lutathera, and the maker of Kisqali and Gleevec."@en ;
  schema:url <https://nuclide.cc/companies/novartis/>, <https://www.novartis.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Novartis> ;
  owl:sameAs <http://www.wikidata.org/entity/Q507154> ;
  schema:citation <https://www.novartis.com> ;
  schema:addressCountry "CH" ;
  nuclide:related <https://nuclide.cc/isotopes/lu-177/>, <https://nuclide.cc/isotopes/ac-225/> ;
  nuclide:drugs <https://nuclide.cc/drugs/pluvicto/>, <https://nuclide.cc/drugs/lutathera/>, <https://nuclide.cc/drugs/ac225-psma/>, <https://nuclide.cc/drugs/fap-2286/>, <https://nuclide.cc/drugs/aaa817/> ;
  nuclide:companies <https://nuclide.cc/companies/mariana-oncology/> ;
  nuclide:trials <https://nuclide.cc/trials/netter-1/>, <https://nuclide.cc/trials/nct05939414/>, <https://nuclide.cc/trials/nct04711135/>, <https://nuclide.cc/trials/nct06894511/>, <https://nuclide.cc/trials/nct06004661/>, <https://nuclide.cc/trials/nct05142696/> .